Are there specific preoperative considerations for patients on SGLT-2 inhibitors with heart failure undergoing surgery?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18203527
Cited by: 0

Abstract

SGLT-2 inhibitors are typically discontinued 2 to 4 days before surgery to minimize eDKA risk. Special consideration is needed for heart failure patients due to potential cardiovascular impacts.

Fields of Study & Subjects

Diabetes Treatment and Management Cardiac Anesthesia and Surgical Outcomes Heart Failure Treatment and Management

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
10 January 2026